Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Главный автор: | Forbes, E |
---|---|
Другие авторы: | Hill, A |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
2011
|
Предметы: |
Схожие документы
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
по: Kapulu, MC
Опубликовано: (2014) -
Developing novel blood-stage malaria vaccines
по: Douglas, AD
Опубликовано: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
по: Bauza, K
Опубликовано: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
по: de Cassan, S
Опубликовано: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
по: Elias, SC
Опубликовано: (2014)